NovaBridge Biosciences Restricted Cash, Current
NovaBridge Biosciences (NBP) had Restricted Cash, Current of CNY 96.76 million as of 2022-12-31, per its 20-F filed 2024-04-30.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:RestrictedCashCurrent · last filed 2024-04-30
- 2022-12-31: Restricted Cash, Current 96.76M CNY.
- 2019-12-31: Restricted Cash, Current 55.81M CNY.
- 2018-12-31: Restricted Cash, Current 92.65M CNY.
CNY
| Period end | Restricted Cash, Current |
|---|---|
| 2022-12-31 | 96.76M CNY 20-F · filed 2024-04-30 |
| 2019-12-31 | 55.81M CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 92.65M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Restricted Cash, Current |
|---|---|
| 2022-12-31 | $14.03M 20-F · filed 2023-05-01 |
| 2019-12-31 | $8.02M 20-F · filed 2020-04-29 |